melatonin has been researched along with Anterior Choroidal Artery Infarction in 16 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The purpose of this study was to evaluate the effect of fluvoxamine maleate, a selective serotonin re-uptake inhibitor (SSRI), on depressive state, sleep disturbance, and serum melatonin levels in patients with depressive state after cerebral infarction." | 9.16 | A preliminary study of fluvoxamine maleate on depressive state and serum melatonin levels in patients after cerebral infarction. ( Katayama, Y; Katsura, K; Nishiyama, Y; Otori, T; Sunami, E; Usuda, K, 2012) |
| "To investigate the mechanism of electroacupuncture in alleviating cerebral ischemia injury in cerebral ischemia-reperfusion rats by regulating melatonin - NOD-like receptor protein 3 (NLRP3) mediated pyroptosis." | 8.31 | [Electroacupuncture alleviates cerebral ischemia injury in rats by regulating melatonin-NLRP3 and inhibiting pyroptosis]. ( Chen, B; Liang, H; Liu, JJ; Luo, J; Ruan, S; Wang, F; Wang, YX; Yan, NW; Zhong, XY, 2023) |
| " Melatonin is neuroprotective against cerebral ischemia-reperfusion injury (CIRI) in non-DM, normoglycemic animals through anti-oxidant effect, anti-inflammation, and anti-apoptosis." | 8.31 | Melatonin mitigates type 1 diabetes-aggravated cerebral ischemia-reperfusion injury through anti-inflammatory and anti-apoptotic effects. ( Cheung, RTF; Xu, Q, 2023) |
| " In this study, the neuroprotective effects of melatonin (Mel) on a rat model of cerebral ischemia/reperfusion injury (CIRI) were assessed by multi-parametric MRI combined with histopathological techniques for longitudinal monitoring of the lesion microenvironment." | 8.31 | Multi-parametric MRI assessment of melatonin regulating the polarization of microglia in rats after cerebral ischemia/reperfusion injury. ( An, L; Bi, F; Gong, P; Li, C; Li, Z; Song, X; Wang, X; Xiao, P; Yu, M; Zhang, M, 2023) |
| "Melatonin treatment significantly decreased infarct volume and cerebral apoptosis; mitigated endoplasmic reticulum stress and mitochondrial dysfunction; and inhibited CI/R injury-induced oxidative/nitrative stress and nuclear factor-κB activation, which was eradicated in RORα-deficient mice." | 5.56 | The circadian nuclear receptor RORα negatively regulates cerebral ischemia-reperfusion injury and mediates the neuroprotective effects of melatonin. ( Ai, L; Gao, L; Gao, Y; Petersen, L; Pu, J; Qin, Z; Tong, R; Yan, Y; Zang, M; Zhao, Y; Zhong, F; Zhu, C, 2020) |
| "In both permanent and transient 3-hour middle cerebral artery occlusion rat stroke models, a single intraperitoneal injection of melatonin at 5 or 15 mg/kg given before ischemia was shown to reduce infarct volume at 72 hours." | 5.32 | Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. ( Cheung, RT; Pang, SF; Pei, Z, 2003) |
| " The purpose of this study was to evaluate the effect of fluvoxamine maleate, a selective serotonin re-uptake inhibitor (SSRI), on depressive state, sleep disturbance, and serum melatonin levels in patients with depressive state after cerebral infarction." | 5.16 | A preliminary study of fluvoxamine maleate on depressive state and serum melatonin levels in patients after cerebral infarction. ( Katayama, Y; Katsura, K; Nishiyama, Y; Otori, T; Sunami, E; Usuda, K, 2012) |
| "To investigate the mechanism of electroacupuncture in alleviating cerebral ischemia injury in cerebral ischemia-reperfusion rats by regulating melatonin - NOD-like receptor protein 3 (NLRP3) mediated pyroptosis." | 4.31 | [Electroacupuncture alleviates cerebral ischemia injury in rats by regulating melatonin-NLRP3 and inhibiting pyroptosis]. ( Chen, B; Liang, H; Liu, JJ; Luo, J; Ruan, S; Wang, F; Wang, YX; Yan, NW; Zhong, XY, 2023) |
| " Melatonin is neuroprotective against cerebral ischemia-reperfusion injury (CIRI) in non-DM, normoglycemic animals through anti-oxidant effect, anti-inflammation, and anti-apoptosis." | 4.31 | Melatonin mitigates type 1 diabetes-aggravated cerebral ischemia-reperfusion injury through anti-inflammatory and anti-apoptotic effects. ( Cheung, RTF; Xu, Q, 2023) |
| " In this study, the neuroprotective effects of melatonin (Mel) on a rat model of cerebral ischemia/reperfusion injury (CIRI) were assessed by multi-parametric MRI combined with histopathological techniques for longitudinal monitoring of the lesion microenvironment." | 4.31 | Multi-parametric MRI assessment of melatonin regulating the polarization of microglia in rats after cerebral ischemia/reperfusion injury. ( An, L; Bi, F; Gong, P; Li, C; Li, Z; Song, X; Wang, X; Xiao, P; Yu, M; Zhang, M, 2023) |
| "Melatonin treatment significantly decreased infarct volume and cerebral apoptosis; mitigated endoplasmic reticulum stress and mitochondrial dysfunction; and inhibited CI/R injury-induced oxidative/nitrative stress and nuclear factor-κB activation, which was eradicated in RORα-deficient mice." | 1.56 | The circadian nuclear receptor RORα negatively regulates cerebral ischemia-reperfusion injury and mediates the neuroprotective effects of melatonin. ( Ai, L; Gao, L; Gao, Y; Petersen, L; Pu, J; Qin, Z; Tong, R; Yan, Y; Zang, M; Zhao, Y; Zhong, F; Zhu, C, 2020) |
| "Melatonin treatment improved the penumbral CBF in the wild-type mice." | 1.33 | Melatonin reduces infarction volume in a photothrombotic stroke model in the wild-type but not cyclooxygenase-1-gene knockout mice. ( Cheung, RT; Huang, L; Li, G; Liu, S; Zou, LY, 2006) |
| "In both permanent and transient 3-hour middle cerebral artery occlusion rat stroke models, a single intraperitoneal injection of melatonin at 5 or 15 mg/kg given before ischemia was shown to reduce infarct volume at 72 hours." | 1.32 | Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. ( Cheung, RT; Pang, SF; Pei, Z, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 5 (31.25) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, D | 1 |
| Liu, Y | 1 |
| Huang, H | 1 |
| Hu, M | 1 |
| Li, T | 1 |
| Wang, S | 1 |
| Shen, S | 1 |
| Wu, R | 1 |
| Cai, W | 1 |
| Lu, T | 1 |
| Lu, Z | 1 |
| Yan, NW | 1 |
| Ruan, S | 1 |
| Wang, F | 1 |
| Wang, YX | 1 |
| Chen, B | 1 |
| Luo, J | 1 |
| Liu, JJ | 1 |
| Liang, H | 1 |
| Zhong, XY | 1 |
| Xu, Q | 1 |
| Cheung, RTF | 1 |
| Li, Z | 1 |
| Gong, P | 1 |
| Zhang, M | 1 |
| Li, C | 1 |
| Xiao, P | 1 |
| Yu, M | 1 |
| Wang, X | 2 |
| An, L | 1 |
| Bi, F | 1 |
| Song, X | 1 |
| Zang, M | 1 |
| Zhao, Y | 1 |
| Gao, L | 1 |
| Zhong, F | 1 |
| Qin, Z | 1 |
| Tong, R | 1 |
| Ai, L | 1 |
| Petersen, L | 1 |
| Yan, Y | 1 |
| Gao, Y | 1 |
| Zhu, C | 1 |
| Pu, J | 1 |
| Yan, C | 1 |
| Zhang, B | 1 |
| Koh, PO | 1 |
| Cam, E | 1 |
| Yulug, B | 1 |
| Cengiz, N | 1 |
| Poelkin, E | 1 |
| Isýk, D | 1 |
| Bakar, M | 1 |
| Ozan, E | 1 |
| Kilic, E | 3 |
| Ulas, UH | 1 |
| Korkmaz, A | 1 |
| Karadas, O | 1 |
| Odabasi, Z | 1 |
| Reiter, RJ | 2 |
| Sunami, E | 1 |
| Usuda, K | 1 |
| Nishiyama, Y | 1 |
| Otori, T | 1 |
| Katsura, K | 1 |
| Katayama, Y | 1 |
| Kilic, U | 1 |
| Yilmaz, B | 1 |
| Yüksel, A | 1 |
| Pei, Z | 2 |
| Pang, SF | 1 |
| Cheung, RT | 3 |
| Zou, LY | 1 |
| Liu, S | 1 |
| Li, G | 1 |
| Huang, L | 1 |
| Ozdemir, YG | 1 |
| Bolay, H | 1 |
| Keleştimur, H | 1 |
| Dalkara, T | 1 |
| Borlongan, CV | 1 |
| Yamamoto, M | 1 |
| Takei, N | 1 |
| Kumazaki, M | 1 |
| Ungsuparkorn, C | 1 |
| Hida, H | 1 |
| Sanberg, PR | 1 |
| Nishino, H | 1 |
| Ho, HT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Study of Memantine for Enhanced Stroke Recovery[NCT02144584] | Early Phase 1 | 20 participants (Anticipated) | Interventional | 2014-01-31 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for melatonin and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
A preliminary study of fluvoxamine maleate on depressive state and serum melatonin levels in patients after cerebral infarction.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cerebral Infarction; Depression; | 2012 |
15 other studies available for melatonin and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Melatonin Offers Dual-Phase Protection to Brain Vessel Endothelial Cells in Prolonged Cerebral Ischemia-Recanalization Through Ameliorating ER Stress and Resolving Refractory Stress Granule.
Topics: Animals; Brain; Brain Ischemia; Cerebral Infarction; Endothelial Cells; Ischemic Stroke; Melatonin; | 2023 |
[Electroacupuncture alleviates cerebral ischemia injury in rats by regulating melatonin-NLRP3 and inhibiting pyroptosis].
Topics: Animals; Brain Injuries; Brain Ischemia; Caspase 1; Cerebral Infarction; Electroacupuncture; Melaton | 2023 |
Melatonin mitigates type 1 diabetes-aggravated cerebral ischemia-reperfusion injury through anti-inflammatory and anti-apoptotic effects.
Topics: Animals; Brain Ischemia; Cerebral Infarction; Diabetes Mellitus, Type 1; Hyperglycemia; Infarction, | 2023 |
Multi-parametric MRI assessment of melatonin regulating the polarization of microglia in rats after cerebral ischemia/reperfusion injury.
Topics: Amides; Animals; Brain Ischemia; Cerebral Infarction; Magnetic Resonance Imaging; Melatonin; Microgl | 2023 |
The circadian nuclear receptor RORα negatively regulates cerebral ischemia-reperfusion injury and mediates the neuroprotective effects of melatonin.
Topics: Animals; Antioxidants; Apoptosis; Brain Ischemia; Cerebral Infarction; Circadian Rhythm; Disease Mod | 2020 |
Clinical significance of detecting serum melatonin and SBDPs in brain injury in preterm infants.
Topics: Brain; Brain Injuries; Case-Control Studies; Cerebral Infarction; Cerebral Intraventricular Hemorrha | 2019 |
Melatonin attenuates the cerebral ischemic injury via the MEK/ERK/p90RSK/bad signaling cascade.
Topics: Animals; bcl-Associated Death Protein; Brain Injuries; Brain Ischemia; Cell Death; Cerebral Infarcti | 2008 |
Melatonin: a suitable agent for depression associated with stroke?
Topics: Animals; Antioxidants; Cerebral Infarction; Depressive Disorder; Humans; Ischemic Attack, Transient; | 2008 |
Sunrise-related headache: case report.
Topics: Adult; Cerebral Infarction; Circadian Rhythm; Cysts; Headache Disorders; Humans; Hypothalamus; Magne | 2010 |
Effects of memantine and melatonin on signal transduction pathways vascular leakage and brain injury after focal cerebral ischemia in mice.
Topics: Analysis of Variance; Animals; Cerebral Cortex; Cerebral Infarction; Corpus Striatum; Disease Models | 2013 |
Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model.
Topics: Animals; Brain Edema; Cerebral Infarction; Disease Models, Animal; Dose-Response Relationship, Drug; | 2003 |
Melatonin reduces infarction volume in a photothrombotic stroke model in the wild-type but not cyclooxygenase-1-gene knockout mice.
Topics: Animals; Brain; Brain Edema; Cerebral Infarction; Cerebrovascular Circulation; Cyclooxygenase 1; Dis | 2006 |
Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia.
Topics: Animals; Blood Pressure; Cerebral Infarction; Cerebrovascular Circulation; Dose-Response Relationshi | 1999 |
Glial cell survival is enhanced during melatonin-induced neuroprotection against cerebral ischemia.
Topics: Animals; Brain Ischemia; Cell Death; Cell Survival; Cerebral Infarction; Free Radical Scavengers; Gl | 2000 |
Pre-treatment with melatonin reduces volume of cerebral infarction in a permanent middle cerebral artery occlusion stroke model in the rat.
Topics: Animals; Blood Pressure; Brain; Cerebral Infarction; Cerebrovascular Circulation; Dose-Response Rela | 2002 |